Robert Lorne Abel Sells 1,300 Shares of Schrodinger (NASDAQ:SDGR) Stock

Schrodinger, Inc. (NASDAQ:SDGR) insider Robert Lorne Abel sold 1,300 shares of the business’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $12.81, for a total transaction of $16,653.00. Following the sale, the insider owned 55,897 shares in the company, valued at $716,040.57. The trade was a 2.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Robert Lorne Abel also recently made the following trade(s):

• On Monday, February 9th, Robert Lorne Abel sold 1,230 shares of Schrodinger stock. The shares were sold at an average price of $13.51, for a total transaction of $16,617.30.

Schrodinger Stock Down 2.2%

Shares of NASDAQ SDGR traded down $0.29 during midday trading on Friday, hitting $12.74. The company had a trading volume of 976,433 shares, compared to its average volume of 1,475,655. The firm has a market capitalization of $938.56 million, a price-to-earnings ratio of -8.97 and a beta of 1.57. Schrodinger, Inc. has a twelve month low of $11.11 and a twelve month high of $27.63. The business has a 50-day simple moving average of $14.88 and a two-hundred day simple moving average of $17.65.

Schrodinger (NASDAQ:SDGR) last issued its earnings results on Wednesday, February 25th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.57. Schrodinger had a negative net margin of 40.37% and a negative return on equity of 29.47%. The company had revenue of $87.24 million during the quarter, compared to analysts’ expectations of $83.66 million. During the same period last year, the company posted ($0.24) earnings per share. The firm’s quarterly revenue was up 4.7% compared to the same quarter last year. On average, equities analysts forecast that Schrodinger, Inc. will post -2.37 EPS for the current year.

Institutional Trading of Schrodinger

A number of hedge funds have recently added to or reduced their stakes in SDGR. Massachusetts Financial Services Co. MA increased its stake in shares of Schrodinger by 38.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 2,072,433 shares of the company’s stock valued at $41,573,000 after acquiring an additional 577,899 shares during the last quarter. Capital Fund Management S.A. acquired a new position in Schrodinger during the second quarter worth approximately $1,486,000. Sumitomo Mitsui Trust Group Inc. increased its position in Schrodinger by 24.8% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,554,569 shares of the company’s stock worth $91,365,000 after purchasing an additional 904,619 shares during the last quarter. Nikko Asset Management Americas Inc. raised its stake in Schrodinger by 7.2% during the second quarter. Nikko Asset Management Americas Inc. now owns 2,591,492 shares of the company’s stock worth $52,089,000 after purchasing an additional 174,684 shares during the period. Finally, Citigroup Inc. boosted its holdings in shares of Schrodinger by 122.5% in the 3rd quarter. Citigroup Inc. now owns 155,209 shares of the company’s stock valued at $3,113,000 after purchasing an additional 85,448 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

SDGR has been the topic of a number of research analyst reports. UBS Group initiated coverage on Schrodinger in a research report on Wednesday, January 7th. They set a “neutral” rating and a $18.00 target price on the stock. Bank of America upgraded shares of Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 price objective on the stock in a research report on Monday, December 15th. Wall Street Zen upgraded shares of Schrodinger from a “sell” rating to a “hold” rating in a report on Saturday, January 31st. Weiss Ratings restated a “sell (e+)” rating on shares of Schrodinger in a research report on Friday, January 9th. Finally, TD Cowen reiterated a “buy” rating on shares of Schrodinger in a research report on Thursday, January 8th. Four research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $21.75.

Trending Headlines about Schrodinger

Here are the key news stories impacting Schrodinger this week:

• Positive Sentiment: Yahoo Finance piece highlights an evolving investment thesis as Schrödinger shifts toward hosted software and resets targets, which could support longer-term sentiment if adoption and ARR trajectory improve. How The Schrödinger (SDGR) Investment Story Is Evolving With Hosted Software And Reset Targets
• Neutral Sentiment: Transcript from Schrödinger’s TD Cowen conference presentation provides management commentary and detail that investors can use to re-assess guidance, product roadmap and commercialization progress; useful but not an immediate catalyst. Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
• Negative Sentiment: CEO Ramy Farid sold 3,661 shares at an average $12.91 (≈1.09% reduction in his stake), a high-profile insider sale that can signal near-term selling pressure. CEO Form 4
• Negative Sentiment: CFO Rachit Jain sold 1,631 shares at ~$12.90 (≈3.01% reduction), adding to the cluster of exec sales that market participants often interpret as a negative signal. CFO Form 4
• Negative Sentiment: Other senior leaders (EVPs Kenneth Lorton and Yvonne Tran, CAO Jenny Herman, and insiders Robert Abel, Karen Akinsanya) executed small-to-moderate sales (roughly 600–1,366 shares each around $12.80–$12.91), collectively reducing insider holdings and contributing to downward pressure. Sample Insider Filing (Robert Abel)
• Negative Sentiment: Multiple filings show these sales occurred within a short window (Mar 4–6), which magnifies market reaction compared with isolated, scheduled sales; however, each sale is a small percentage of total insider stakes and could reflect diversification or option/vesting activity rather than a change in corporate outlook. SEC Filings

About Schrodinger

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.